Shanghai, China

Bin Gui

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Bin Gui

Introduction

Bin Gui is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of pyrazolopyrimidone derivatives. With a total of three patents to his name, his work focuses on therapeutic applications that address critical health issues.

Latest Patents

Bin Gui's latest patents include innovative methods and uses of pyrazolopyrimidone derivatives. One of his patents describes these derivatives and their pharmaceutical applications, particularly as gonadotropin-releasing hormone (GnRH) antagonists. This has potential therapeutic implications for conditions such as endometriosis. Another patent outlines methods of preparing these derivatives and their pharmaceutical uses, emphasizing their importance in medical treatments.

Career Highlights

Throughout his career, Bin Gui has worked with prominent companies in the pharmaceutical industry, including Shanghai Hengrui Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His experience in these organizations has allowed him to contribute to significant advancements in drug development.

Collaborations

Bin Gui has collaborated with notable colleagues, including Hejun Lu and Piaoyang Sun. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.

Conclusion

Bin Gui's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic agents, particularly for conditions like endometriosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…